» Authors » Jessica Gasparello

Jessica Gasparello

Explore the profile of Jessica Gasparello including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 581
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gambari R, Papi C, Gasparello J, Agostinelli E, Finotti A
Exp Ther Med . 2025 Mar; 29(4):85. PMID: 40084194
The coronavirus disease-19 (COVID-19) pandemic has been a very significant health issue in the period between 2020 and 2023, forcing research to characterize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
2.
Gasparello J, Ceccon C, Angerilli V, Comunello T, Sabbadin M, DAlmeida Costa F, et al.
J Liq Biopsy . 2025 Mar; 7:100288. PMID: 40027230
Circulating tumor DNA (ctDNA) is nowadays considered a robust source to search for druggable tumoral genetic alterations, and in some specific settings liquid biopsy (LB) is already part of the...
3.
Gasparello J, Papi C, Marzaro G, Macone A, Zurlo M, Finotti A, et al.
Molecules . 2025 Jan; 29(24. PMID: 39770027
Garlic ( L.) is a species of the onion family () widely used as a food and a folk medicine. The objective of this study was to determine the effects...
4.
Ceccon C, Borga C, Angerilli V, Bergamo F, Munari G, Sabbadin M, et al.
Pathol Res Pract . 2024 Dec; 266:155786. PMID: 39724851
Background: RAS/BRAF mutations, mismatch DNA repair complex deficiency (MMRd)/microsatellite instability (MSI), and CpG methylator phenotype (CIMP) are key molecular actors in colorectal carcinogenesis. To date, conflicting evidence about the correlations...
5.
Angerilli V, Vanoli A, Celin G, Ceccon C, Gasparello J, Sabbadin M, et al.
Mod Pathol . 2024 Apr; 37(6):100491. PMID: 38588886
Patients with autoimmune gastritis (AIG) have a 13-fold risk of developing type-1 neuroendocrine tumors, whereas the risk for gastric adenocarcinoma is still uncertain. Here we describe the clinicopathologic and molecular...
6.
Prete A, Angerilli V, Bergamo F, Vettore V, De Toni C, Intini R, et al.
Br J Cancer . 2024 Feb; 130(8):1316-1323. PMID: 38347094
Background: Little is known about prognostic factors of brain metastases (BM) from colorectal cancer (CRC). HER2 amplification/overexpression (HER2+) was previously described; its impact on prognosis remains uncertain. Methods: In the...
7.
Zurlo M, Gasparello J, Verona M, Papi C, Cosenza L, Finotti A, et al.
Exp Cell Res . 2023 Nov; 433(2):113853. PMID: 37944576
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causative of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The SARS-CoV-2 Spike protein (S-protein) plays an important role in the early...
8.
Cosenza L, Marzaro G, Zurlo M, Gasparello J, Zuccato C, Finotti A, et al.
Exp Hematol . 2023 Nov; 129:104128. PMID: 37939833
During the recent coronavirus disease 2019 (COVID-19) pandemic several patients with β-thalassemia have been infected by severe acute respiratory syndrome coronavirus (SARS-CoV-2), and most patients were vaccinated against SARS-CoV-2. Recent...
9.
Finotti A, Gasparello J, Zuccato C, Cosenza L, Fabbri E, Bianchi N, et al.
Genes (Basel) . 2023 Oct; 14(10). PMID: 37895276
The anticancer drug mithramycin (MTH), has been proposed for drug repurposing after the finding that it is a potent inducer of fetal hemoglobin (HbF) production in erythroid precursor cells (ErPCs)...
10.
Zurlo M, Zuccato C, Cosenza L, Gasparello J, Gamberini M, Stievano A, et al.
Int J Mol Sci . 2023 Oct; 24(20). PMID: 37894732
The β-thalassemias are hereditary monogenic diseases characterized by a low or absent production of adult hemoglobin and excess in the content of α-globin. This excess is cytotoxic for the erythroid...